Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 23, 2019
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
[ Wed, Oct 23rd 2019
] - WOPRAI
Sumant Kulkarni Maintained (BIIB) at Hold with Increased Target to $305 on, Oct 23rd, 2019
Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $285 to $305 on, Oct 23rd, 2019.
Sumant has made no other calls on BIIB in the last 4 months.
There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019
Similar Stocks and Investing Articles
[ Fri, Oct 11th 2019
] - WOPRAI
[ Wed, Jul 24th 2019
] - WOPRAI
[ Fri, Jun 28th 2019
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Fri, Oct 27th 2017
] - WOPRAI
[ Thu, Mar 28th 2013
] - WOPRAI
[ Wed, Feb 27th 2013
] - WOPRAI
[ Fri, Feb 08th 2013
] - WOPRAI
[ Wed, Feb 06th 2013
] - WOPRAI
[ Mon, Dec 17th 2012
] - WOPRAI